Evidence Infrastructure
A Peptide Name Is Not a Complete Molecular Identity
An ambiguous peptide label becomes useful only when it can be tied to a traceable molecular record. Similar or synonymous names do not guarantee identical products.
Educational content only. Not medical advice.
Common names can point to families rather than one structure
A peptide may be known by a hormone name, gene-derived name, development code, catalog label, historical abbreviation, or functional nickname. The same alias can be used for different fragments, species, salts, terminal forms, or analogues. Conversely, one defined molecule may have several names. A record should preserve the source's wording while resolving it to a sequence and molecular form instead of silently choosing the most familiar interpretation.
Precursor coordinates distinguish mature products
Gene-encoded peptides often come from larger preproproteins. Signal peptides, pro-regions, cleavage sites, amidation donors, and tissue-specific processing determine the mature chains. Feature coordinates should reference a versioned canonical sequence, organism, and database accession. A mature hormone can be only a small region of the precursor, and two tissues may process the same precursor into different peptide sets.
Chemical identity extends beyond amino-acid letters
N- and C-terminal chemistry, amidation, acetylation, disulfides, cyclization, phosphorylation, glycosylation, lipidation, isotopes, noncanonical residues, and D stereochemistry can define a distinct peptidoform. Counterions and solvation affect material composition even when they do not change covalent sequence. A bare one-letter string omits these attributes. Standardized notation such as ProForma helps encode modifications, but evidence must still establish their location.
A minimum identity record is explicit and versioned
Record primary name, aliases, organism, gene or precursor, accession and version, mature coordinates, exact sequence, terminal groups, modifications, connectivity, stereochemistry, conjugates, and source date. For a manufactured product, add counterion, purity basis, and analytical evidence. This structure supports search, comparison, and updates while making unknowns visible. It does not authenticate a label or imply that two materials with matching names are interchangeable.
Evidence limits
- Names and annotations can change as databases and nomenclature committees update records.
- Notation describes an intended form but does not prove a sample contains that form.
- Matching labels do not establish product equivalence, purity, or suitability.
Sources and further reading
These sources ground the definitions and evidence boundaries on this page. A citation is a route for verification, not an endorsement of a product or personal use.
UniProt Consortium
Sequences
Official guidance on canonical sequences, isoforms, amino-acid notation, length, mass, and sequence provenance.
Open sourceHUPO Proteomics Standards Initiative
ProForma 2.0: Unifying the Encoding of Proteoforms and Peptidoforms
Primary community standard for representing modified peptide and protein sequences.
Open sourceCommon questions
Is the peptide name enough to calculate molecular mass?
No. Exact sequence, termini, modifications, connectivity, and sometimes counterion or isotope information are needed.
Why record precursor coordinates?
They show exactly which mature region was derived from which versioned source sequence.
Can two peptides have the same sequence but different identity?
Yes. Terminal chemistry, stereochemistry, modifications, disulfide connectivity, conjugates, and formulation can differ.
Continue with context
Continue in the evidence workspace
Explore the complete PeptideSchool research workspace to organize sources, compare evidence layers, and follow related peptide science. Premium tools remain educational and do not provide individualized medical guidance.